Of model hosts and man: Using Caenorhabditis elegans, Drosophila melanogaster and Galleria mellonella as model hosts for infectious disease research

Advances in Experimental Medicine and Biology

Volumn 710, Issue , 2012, Pages 11-17

  Glavis Bloom, Justin ^a   Muhammed, Maged ^a   Mylonakis, Eleftherios ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ATTACIN; CAFFEIC ACID PHENETHYL ESTER; CECROPIN; DEFENSIN; DIPTERICIN; DROSOCIN; DROSOMYCIN; ENOXACIN; FLUCYTOSINE; HEAT SHOCK PROTEIN 90 INHIBITOR; METCHNIKOWIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; CRYPTOCOCCOSIS; DROSOPHILA MELANOGASTER; DRUG EFFICACY; FUNGAL VIRULENCE; GALLERIA MELLONELLA; HOST PATHOGEN INTERACTION; INNATE IMMUNITY; LARVA; MOTH; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ANIMALS; BACTERIAL INFECTIONS; CAENORHABDITIS ELEGANS; COMMUNICABLE DISEASES; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; HUMANS; IMMUNITY, INNATE; MOTHS; MYCOSES;

CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; GALLERIA MELLONELLA; INVERTEBRATA; MAMMALIA;

EID: 84555188797     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-5638-5_2     Document Type: Article

References (41)

1. Alarco AM et al (2004) Immune-deficient Drosophila melanogaster: A model for the innate immune response to human fungal pathogens. J Immunol 172:5622-5628
2. Apidianakis Y et al (2004) Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response. Eukaryot Cell 3:413-419 (Pubitemid 38497980)
3. Bazopoulou D, Tavernarakis N (2009) The NemaGENETAG initiative: Large scale transposon insertion gene-tagging in Caenorhabditis elegans. Genetica 137:39-46
4. Begun J, Sifri CD, Goldman S, Calderwood SB, Ausubel FM (2005) Staphylococcus aureus virulence factors identified by using a high-throughput Caenorhabditis elegans-killing model. Infect Immun 73:872-877 (Pubitemid 40165745)
5. Breger J et al (2007) Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 3:e18
6. Brennan M, Thomas DY, Whiteway M, Kavanagh K (2002) Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol Med Microbiol 34:153-157
7. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77:71-94
8. Chamilos G et al (2006) Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis 193:1014-1022
9. Coleman JJ et al (2010) Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem Biol 5:321-332
10. Cotter G, Doyle S, Kavanagh K (2000) Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol Med Microbiol 27:163-169 (Pubitemid 30047095)
11. Cowen LE et al (2009) Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci USA 106:2818-2823
12. Diaz MH et al (2008) Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect Immun 76:4414-4421
13. Douglas LJ (2003) Candida biofilms and their role in infection. Trends Microbiol 11:30-36 (Pubitemid 36084353)
14. Fire A et al (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811 (Pubitemid 28099681)
15. Fuchs BB et al (2010) Role of filamentation in Galleria mellonella killing by Candida albicans. Microbes Infect 12:488-496
16. Garvis S et al (2009) Caenorhabditis elegans semi-automated liquid screen reveals a specialized role for the chemotaxis gene cheB2 in Pseudomonas aeruginosa virulence. PLoS Pathog 5:e1000540
17. Giacomotto J, Ségalat L (2010) High-throughput screening and small animal models, where are we? Br J Pharmacol 160:204-216
18. Hoffmann J (2003) The immune response of Drosophila. Nature 426:33-38 (Pubitemid 37432534)
19. Kavanagh K, Fallon JP (2010) Galleria mellonella larvae as models for studying fungal virulence. Fungal Biol Rev 24:79-83
20. Kurz CL et al (2003) Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. EMBO J 22:1451-1460 (Pubitemid 36417394)
21. Lemaitre B (2004) The road to toll. Nat Rev Immunol 4:521-527 (Pubitemid 38931767)
22. Lemaitre B, Hoffmann J (2007) The host defense of Drosophila melanogaster. Annu Rev Immunol 25:697-743 (Pubitemid 46697922)
23. Lemaitre B, Reichhart JM, Hoffmann JA (1997) Drosophila host defense: Differential induction of antimicrobial peptide genes after infection by various classes of microorganisms. Proc Natl Acad Sci USA 23:14614-14619 (Pubitemid 28041422)
24. Lindsay MA (2003) Target discovery. Nat Rev Drug Discov 2:831-838 (Pubitemid 37361815)
25. Lionakis MS et al (2005) Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence. J Infect Dis 191:1188-1195 (Pubitemid 40404379)
26. Mahajan-Miklos S, Tan MW, Rahme LG, Ausubel FM (1999) Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 96:47-56 (Pubitemid 29044152)
27. Mowlds P, Kavanagh K (2008) Effect of pre-incubation temperature on susceptibility of Galleria mellonella larvae to infection by Candida albicans. Mycopathologia 165:5-12 (Pubitemid 351153279)
28. Moy T et al (2009) High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem Biol 4:527-533
29. Mueller NJ, Fishman JA (2003) Asymptomatic pulmonary cryptococcosis in solid organ transplantation: Report of four cases and review of the literature. Transpl Infect Dis 5:140-143 (Pubitemid 37356357)
30. Mylonakis E (2008) Galleria mellonella and the study of fungal pathogenesis: Making the case for another genetically tractable model host. Mycopathologia 165:1-3
31. Mylonakis E et al (2004) Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals. Mol Microbiol 54:407-419 (Pubitemid 39388285)
32. Mylonakis E et al (2005) Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 73:3842-3850 (Pubitemid 40923121)
33. O'Callaghan D, Vergunst A (2010) Non-mammalian animal models to study infectious disease: Worms or fly fishing? Curr Opin Microbiol 13:79-85
34. Okoli I et al (2009) Identification of antifungal compounds active against Candida albicans using an improved highthroughput Caenorhabditis elegans assay. PLoS One 4:e7025
35. Pukkila-Worley R, Peleg A, Tampakakis E, Mylonakis E (2009) Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot Cell 8:1750-1758
36. Riddle DL, Blumenthal T, Meyer BG, Priess JR (1997) C. elegans II, 2nd edn. Cold Spring Harbor Laboratory Press, Plainview
37. Rizki RM, Rizki TM (1984) Selective destruction of a host blood cell type by a parasitoid wasp. Proc Natl Acad Sci USA 81:6154-6158 (Pubitemid 15220798)
38. Rowan R, Moran C, McCann M, Kavanagh K (2009) Use of Galleria mellonella larvae to evaluate the in vivo antifungal activity of [Ag2(mal)(phen)3]. Biometals 22:461-467
39. Sekiya M et al (2008) A cyclopentanediol analogue selectively suppresses the conserved innate immunity pathways, Drosophila IMD and TNF-alpha pathways. Biochem Pharmacol 75:2165-2174
40. Spring DR (2005) Chemical genetics to chemical genomics: Small molecules offer big insights. Chem Soc Rev 34:472-482 (Pubitemid 40880427)
41. Tan MW, Rahme LG, Sternberg JA, Tompkins RG, Ausubel FM (1999) Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc Natl Acad Sci USA 96:2408-2413 (Pubitemid 29117928)